ArticlePloS one2019

Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.

Kirti Kandhwal Chahal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.